Psychological Treatments

BARRIERS TO TREATMENTS
  1. systemic external barriers cost
  • study from 2016, the cost of treating depressive disorders in US 71 billion dollars in out-of-pocket costs between both patients and insurance programs
  • up to $150 cost for one hour of cognitive behvaiour therapy in CAN
  • estimates show that for every ten patients with adult ADHD only one will receive ADHD specific treatment that year.
  1. they could be facing internal barriers to treatment: their own restrictive beliefs about their disorder
  • ego dystonic :: they have neg relationship w the disorder. recognizes the issues + dislikes the symptoms
  • ego systonic :: they have pos relationship w the disorder. they hv accepted their disorder + hc found ways to embrace it

stages of change :: precontemplation, contemplation, preparation, action, maintenance (relapse)

precontemplation :: inability or unwillingness to acknowledge the existence of a problem. ego syntonic

contemplation :: indiv acknowledges the existence of the problem but may be unsure or unwilling to change the problem. ego dystonic

preparation :: indivs recognize the problwm and prep for change

action :: taking active steps to change the behaviour

maintenance :: indivs continue the healthy habits formed at the action stage

relapse :: the full return of old, unhealthy behaviours, often driving the afflicted indiv all the way back to the precontemplation stage of change

 

DESIGNING TREATMENT

efficacy trials :: test the treatment on the ideal participants, and tightly monitor those participants’ adherence to the treatment plan. if sucessful researchers can go to effectiveness trials

effectiveness trials :: researchers now want to know if treatments shown to work in the earlier efficacy trials will still work once tested on most patients in most settings.

APPROACHES TO TREATMENT

 

psychotic symptoms correlated with increased dopamine. Thus, antipsychotic medications attempt to reduce psychotic symptoms by reducing dopamine activity. The antipsychotic medications bind and hold onto postsynaptic dopamine receptors, preventing the dopamine from \n binding and rendering it ineffective.

 

  \n